Giuseppe Curigliano, Joyce O'Shaughnessy, François Clément Bidard, Sung-Bae Kim, Eriko Tokunaga, Philippe Georges Aftimos, Cristina Saura Manich, Lisa A. Carey, Meena Okera, Éverton Melo, Flora Zagouri, Manuel Magallanes, Nuri Karadurmus, Shakeela Wazeen Bahadur, Rebecca M. Speck, Xuejing Aimee Wang, Suzanne R.L. Young, Komal L. Jhaveri, Nadia Harbeck. "Patient-reported outcomes (PROs) in patients with ER+, HER2- advanced breast cancer (ABC) treated with imlunestrant, investigator’s choice standard endocrine therapy, or imlunestrant + abemaciclib: Results from the phase III EMBER-3 trial.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.1001